Financial PerformanceADPT pre-announced revenues above the Street, indicating stronger than expected financial performance.
Product DemandClonoSEQ MRD volumes grew significantly, with a 49% year-over-year increase, indicating strong product demand.
Strategic Business UpdateConclusion of strategic review results in the company keeping the MRD and IM businesses separate within ADPT, while implementing dedicated resources and segment reporting structures for each.